Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Intelsius Enhances Patient Safety Products

Published: Thursday, February 13, 2014
Last Updated: Wednesday, February 12, 2014
Bookmark and Share
Company announces enhancement to ThermoTrek™ range of solutions.

Intelsius has announced an enhancement to its ThermoTrek™ range of solutions. They now feature ThermoCline Technology™ (TCT) allowing 48 plus hours of protection for temperature sensitive payloads. The TCT addition allows for simple conditioning of a single component making it easy for patients to use correctly.

ThermoTrek systems are a range of insulated, patient carry cases designed for movement of temperature sensitive medications (2-8 degrees C) either being tested in clinical trials or for approved and marketed medicines used by patients.

“Pharmaceutical companies make enormous investments in their IMPs during clinical trials and the ThermoTrek TCT systems will help patients comply with temperature sensitivity requirements and provide more reliable clinical data outcomes,” said Steve Healy, Intelsius Global Sales Director.

In commercially available temperature sensitive medicines, the system protects the patient’s investment in treatment while ensuring efficacy of the medicine.

The optional Thermochromic label on the TCT panel visually indicates and verifies the readiness for use.

“Keeping patients safe is the primary reason for the ThermoTrek TCT line of products and simplified conditioning makes it extremely easy for them to use,” said Healy. “In addition, we’ve already had great feedback from leading Pharma companies who are shipping high value biologics direct to pharmacies here in Europe.”

Every ThermoTrek TCT solution is constructed with high performance materials which give a strong resistance to tears or abrasions while offering stain and water resistance for many months of reliable use.

Each case is ergonomically designed to have a minimum impact on the patient’s daily life and enable comfortable transportation of medicine. In addition, its discreet design keeps the contents confidential.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!